The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study

Overview of attention for article published in Clinical Interventions in Aging, February 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 4,306 followers.

RT @GRUPOCRONOSSEF1: 📝Eficacia de RIVASTIGMINA TRANSDÉRMICA en enf. de Alzheimer de leve a moderada con enfermedad CV concomitante de vasos…

21 Apr 2021

Reply Repost Favourite

RT @GRUPOCRONOSSEF1: 📝Eficacia de RIVASTIGMINA TRANSDÉRMICA en enf. de Alzheimer de leve a moderada con enfermedad CV concomitante de vasos…

21 Apr 2021

Reply Repost Favourite

RT @GRUPOCRONOSSEF1: 📝Eficacia de RIVASTIGMINA TRANSDÉRMICA en enf. de Alzheimer de leve a moderada con enfermedad CV concomitante de vasos…

21 Apr 2021

Reply Repost Favourite

📝Eficacia de RIVASTIGMINA TRANSDÉRMICA en enf. de Alzheimer de leve a moderada con enfermedad CV concomitante de vasos pequeños. https://t.co/DSJP5CUOiK

21 Apr 2021

Reply Repost Favourite

Dove Medical Press

Article Metrics

The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study

About this Attention Score

Mentioned by

Citations

Readers on